These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 6141519

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Direct assessment of splanchnic uptake and metabolic effects of human and porcine insulin.
    Saccà L, Orofino G, Petrone A, Vigorito C.
    J Clin Endocrinol Metab; 1984 Aug; 59(2):191-6. PubMed ID: 6145721
    [Abstract] [Full Text] [Related]

  • 3. Feedback inhibition by biosynthetic human insulin of insulin release in healthy human subjects.
    Waldhäusl WK, Gasić S, Bratusch-Marrain P, Korn A, Nowotny P.
    Am J Physiol; 1982 Dec; 243(6):E476-82. PubMed ID: 6756164
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of somatostatin on insulin and glucose levels during insulin infusion in anesthetized dogs.
    O'Brien DW, Molnar GD, Petersen TD, Rajotte RV.
    Pancreas; 1990 Nov; 5(6):652-7. PubMed ID: 1980734
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effects of biosynthetic human proinsulin on carbohydrate metabolism.
    Revers RR, Henry R, Schmeiser L, Kolterman O, Cohen R, Bergenstal R, Polonsky K, Jaspan J, Rubenstein A, Frank B.
    Diabetes; 1984 Aug; 33(8):762-70. PubMed ID: 6378699
    [Abstract] [Full Text] [Related]

  • 10. Somatostatin infusion enhances hepatic glucose production during hyperglucagonemia.
    Meneilly GS, Minaker KL, Elahi D, Rowe JW.
    Metabolism; 1988 Mar; 37(3):252-6. PubMed ID: 2893970
    [Abstract] [Full Text] [Related]

  • 11. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T, Röjdmark S, Bloom G, Chou MC, Field JB.
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
    Gumbiner B, Polonsky KS, Beltz WF, Griver K, Wallace P, Brechtel G, Henry RR.
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
    [Abstract] [Full Text] [Related]

  • 15. Somatostatin impairs clearance of exogenous insulin in humans.
    Ipp E, Sinai Y, Bar-Oz B, Nesher R, Cerasi E.
    Diabetes; 1987 May; 36(5):673-7. PubMed ID: 2883058
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Measurement of C-peptide concentrations and responses to somatostatin, glucose infusion, and insulin resistance in horses.
    Tóth F, Frank N, Martin-Jiménez T, Elliott SB, Geor RJ, Boston RC.
    Equine Vet J; 2010 Mar; 42(2):149-55. PubMed ID: 20156251
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.